1.
Al-Wataify A. EFFICACY AND SAFETY OF DEFERASIROX THERAPY ON β-THALASSEMIA MAJOR PATIENTS IN BABYLON THALASSEMIA CENTER. JSMC [Internet]. 2013 Dec. 1 [cited 2024 Jul. 3];3(2):125-30. Available from: https://jsmc.univsul.edu.iq/index.php/jsmc/article/view/jsmc-10041